Total Payments
$3,498
2023 Payments
$38.39
Companies
23
Transactions
266
Medicare Patients
3,223
Medicare Billing
$245,595
Payment Breakdown by Category
Food & Beverage$3,360 (96.0%)
Other$95.00 (2.7%)
Education$43.29 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,360 | 261 | 96.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95.00 | 1 | 2.7% |
| Education | $43.29 | 4 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $430.95 | 82 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $422.81 | 30 | $0 (2020) |
| Novo Nordisk Inc | $382.79 | 23 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $328.15 | 25 | $0 (2020) |
| Allergan Inc. | $301.95 | 12 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $276.82 | 16 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $207.17 | 13 | $0 (2022) |
| Lilly USA, LLC | $192.85 | 13 | $0 (2019) |
| Amgen Inc. | $186.93 | 12 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $168.00 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $38.39 | 2 | ABBVIE INC. ($22.09) |
| 2022 | $217.45 | 12 | Takeda Pharmaceuticals U.S.A., Inc. ($156.24) |
| 2020 | $288.62 | 16 | Novo Nordisk Inc ($59.23) |
| 2019 | $1,056 | 76 | Novo Nordisk Inc ($220.92) |
| 2018 | $879.55 | 79 | Boehringer Ingelheim Pharmaceuticals, Inc. ($134.93) |
| 2017 | $1,018 | 81 | Allergan Inc. ($211.87) |
All Payment Transactions
266 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $0.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 07/01/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/10/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 01/27/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/10/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.55 | General |
| 02/25/2020 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: VACCINES | ||||||
| 02/21/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/20/2020 | PFIZER INC. | CHANTIX (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/13/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: NEUROSCIENCE | ||||||
| 02/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2020 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: VACCINE | ||||||
| 01/23/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 875 | 1,011 | $206,514 | $67,177 |
| 2022 | 14 | 865 | 999 | $210,149 | $66,830 |
| 2021 | 14 | 671 | 807 | $184,741 | $58,281 |
| 2020 | 12 | 812 | 969 | $166,608 | $53,308 |
Total Patients
3,223
Total Services
3,786
Medicare Billing
$245,595
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 12 | 18 | $2,376 | $663.68 | 27.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 20 | 20 | $820.00 | $576.76 | 70.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $697.00 | $487.22 | 69.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 27 | 27 | $972.00 | $282.54 | 29.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 150 | 274 | $87,654 | $23,750 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 107 | 107 | $34,806 | $14,106 | 40.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 77 | 77 | $16,511 | $5,535 | 33.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 59 | $13,292 | $3,091 | 23.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 13 | 13 | $5,434 | $2,176 | 40.0% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 12 | 14 | $7,091 | $2,061 | 29.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 16 | 16 | $3,696 | $1,997 | 54.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 87 | 87 | $3,994 | $1,588 | 39.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $5,915 | $1,460 | 24.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 79 | 79 | $3,626 | $1,442 | 39.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 17 | 17 | $578.00 | $349.01 | 60.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 20 | 20 | $900.00 | $331.70 | 36.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $720.00 | $265.44 | 36.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $524.00 | $130.24 | 24.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 134 | 246 | $67,158 | $17,879 | 26.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 109 | 109 | $31,392 | $12,524 | 39.9% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 107 | 107 | $23,219 | $9,061 | 39.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 83 | 120 | $22,560 | $5,622 | 24.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 12 | 14 | $8,526 | $2,714 | 31.8% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 98 | 98 | $4,410 | $1,748 | 39.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 91 | 91 | $4,095 | $1,625 | 39.7% |
About Dr. Danny Fox, M.D
Dr. Danny Fox, M.D is a Family Medicine healthcare provider based in Oldsmar, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568416816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Danny Fox, M.D has received a total of $3,498 in payments from pharmaceutical and medical device companies, with $38.39 received in 2023. These payments were reported across 266 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,360).
As a Medicare-enrolled provider, Fox has provided services to 3,223 Medicare beneficiaries, totaling 3,786 services with total Medicare billing of $245,595. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Oldsmar, FL
- Active Since 05/20/2006
- Last Updated 08/15/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1568416816
Products in Payments
- FARXIGA (Drug) $320.68
- JANUVIA (Drug) $179.61
- TRINTELLIX (Drug) $156.24
- NAMENDA XR (Drug) $139.42
- Ozempic (Drug) $133.99
- SOLIQUA (Drug) $132.49
- JARDIANCE (Drug) $124.25
- CHANTIX (Drug) $111.01
- Tresiba (Drug) $102.56
- Prolia (Biological) $98.10
- LYRICA (Drug) $94.99
- INVOKANA (Drug) $91.53
- XIFAXAN (Drug) $91.08
- ELIQUIS (Drug) $89.71
- TRULICITY (Drug) $77.98
- SYMBICORT (Drug) $71.32
- BASAGLAR (Drug) $70.90
- PREVNAR - 13 (Biological) $66.21
- TRADJENTA (Drug) $65.32
- ZOSTAVAX (Biological) $64.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Oldsmar
Howard Chipman, M.d, M.D
Family Medicine — Payments: $69,441
Family Medicine $69,441
Dr. Juan Falla, M.d, M.D
Family Medicine — Payments: $3,116
Family Medicine $3,116
Dr. David Hughes, M.d, M.D
Family Medicine — Payments: $2,549
Family Medicine $2,549
Robert Dimasi, D.o, D.O
Family Medicine — Payments: $772.14
Family Medicine $772.14
Annie Thomas, Md, MD
Family Medicine — Payments: $495.26
Family Medicine $495.26
Naxdaris Gonzalez, Md, MD
Family Medicine
Family Medicine